Eiffage (FR:FGR) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Eiffage, in partnership with Fouchard and Sner, has secured a €72 million contract to expand and renovate the Henri Becquerel cancer treatment center in Rouen, France. Eiffage’s share of the project, which aims to enhance patient experience with sustainable and energy-efficient designs, is valued at €50 million. Construction has commenced with completion expected by 2026, ensuring continuous patient care during the process.
For further insights into FR:FGR stock, check out TipRanks’ Stock Analysis page.